## HER2-Targeted Therapy and Cardiotoxicity Management **Key Point:** Trastuzumab-induced cardiomyopathy is dose-dependent and can be reversible if detected early and managed appropriately. A decline in LVEF of ≥10 percentage points or to <50% warrants temporary discontinuation and cardiology evaluation. ### Mechanism of Trastuzumab Cardiotoxicity Trastuzumab blocks HER2 signaling in cardiac myocytes, impairing survival pathways and leading to: - Reduced contractility - Myocyte apoptosis - Reversible left ventricular dysfunction (unlike anthracycline-induced irreversible damage) ### Management Algorithm for LVEF Decline ```mermaid flowchart TD A[LVEF decline detected on echo]:::outcome --> B{Magnitude of decline?}:::decision B -->|≥10% drop OR LVEF <50%| C[Withhold trastuzumab]:::action B -->|<10% AND LVEF ≥50%| D[Continue with close monitoring]:::action C --> E[Repeat echo in 3-4 weeks]:::action E --> F{LVEF recovery?}:::decision F -->|Yes, back to baseline| G[Resume trastuzumab with cardio monitoring]:::action F -->|No or worsening| H[Cardiology consultation; consider alternative HER2 therapy]:::action D --> I[Echo every 3 months]:::action ``` **High-Yield:** The 10% decline threshold (or absolute LVEF <50%) is the standard trigger for trastuzumab interruption in clinical practice and trials (HERA, ToGA). **Clinical Pearl:** Unlike anthracycline cardiomyopathy, trastuzumab-induced dysfunction is often reversible. Withholding the drug allows myocardial recovery in 50–60% of cases, permitting re-challenge after LVEF normalization. ### Why Withhold Rather Than Continue? - Continued exposure risks progression to symptomatic heart failure - Early detection + temporary cessation = high likelihood of LVEF recovery - Asymptomatic status does NOT exclude significant risk; subclinical LV dysfunction precedes overt HF **Tip:** Always obtain baseline LVEF before starting trastuzumab, then monitor at 3, 6, and 12 months, or sooner if symptoms develop. [cite:Harrison 21e Ch 109]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.